Cargando…
Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis
The main cause of cancer-associated deaths is the spread of cancer cells to distant organs. Despite its success in the primary tumor setting, modern chemotherapeutic strategies are rendered ineffective at treating metastatic disease, largely due to the development of resistance. The adaptor protein...
Autores principales: | Hoskin, Victoria, Ghaffari, Abdi, Laight, Brian J., SenGupta, Sandip, Madarnas, Yolanda, Nicol, Christopher J.B., Elliott, Bruce E., Varma, Sonal, Greer, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010290/ https://www.ncbi.nlm.nih.gov/pubmed/36923551 http://dx.doi.org/10.1158/2767-9764.CRC-21-0117 |
Ejemplares similares
-
Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer
por: Ghaffari, Abdi, et al.
Publicado: (2019) -
A novel role for ezrin in breast cancer angio/lymphangiogenesis
por: Ghaffari, Abdi, et al.
Publicado: (2014) -
Erratum to: “A novel role for ezrin in breast cancer angio/lymphangiogenesis”
por: Ghaffari, Abdi, et al.
Publicado: (2015) -
Ezrin, more than a metastatic detERMinant?
por: Hoskin, Victoria, et al.
Publicado: (2019) -
A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor‐positive disease
por: Storr, Sarah J., et al.
Publicado: (2023)